Abstract:Background and objective: The cysteine protease cathepsin K is elevated in both human and animal models of heart failure. Global deletion of cathepsin K attenuates both high fat diet- and pressure overload-induced cardiac hypertrophy and contractile dysfunction, although the role of cardiac cathepsin K remains unclear. To this end, the objective of this study was to generate a cardiomyocyte-specific knockout of cathepsin K ( Ctsk -/- ) and to test the hypothesis that deletion of cardiac cathepsin K protects against doxorubicin-induced cardiotoxicity. Methods: Ctsk -/- mice were generated by Ctsk targeted trap-allele including both FLP-FRT and Cre-lox systems. Cre-recombinase in myosin-heavy chain-Cre transgenic mice recognizes LoxP sites in “floxed (flanked by LoxP)” mice, and deletes the exons from 2 to 5 of Ctsk . Protein and mRNA levels of Ctsk and exon 2 were determined by Western blot and quantitative RT-PCR respectively. Four-months-old control (fl/fl-Cre - ) and Ctsk -/- (fl/fl-Cre + ) mice received two injections of doxorubicin (10mg/kg, i.p. at 3-day intervals, 20mg/kg cumulative), one week following which, body and tissue weight, echocardiographic properties, cardiomyocyte contractile function and Ca 2+ -handling were evaluated. Results: Cathepsin K mRNA and protein were attenuated by over 80% in the hearts of the knockout mice compared to the control. Doxorubicin injections resulted in an increase in total heart mass and the length of individual cardiomyocytes. Furthermore, doxorubicin-treated mice exhibited cardiomyocyte contractile dysfunction, characterized by depressed peak-shortening, maximal velocity of shortening and re-lengthening, and impaired intracellular Ca 2+ homeostasis. Additionally, mice receiving doxorubicin exhibited significant increases in end-systolic and end-diastolic diameters and decreased fractional shortening and wall thickness. These deleterious cardiac effects of doxorubicin were significantly attenuated or reversed in mice lacking cardiac cathepsin K. Conclusion: Mitigation of doxorubicin-induced cardiac anomalies by targeted deletion of cardiac cathepsin K suggests that cathepsin K represents a novel, bona-fide, pharmacological target for cardiac toxicity and complications.

Cathepsin B Deficiency Attenuates Cardiac Remodeling in Response to Pressure Overload Via TNF-α/ASK1/JNK Pathway

Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.

Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.

Cathepsin B in cardiovascular disease: Underlying mechanisms and therapeutic strategies

Cathepsin S Deficiency Results in Abnormal Accumulation of Autophagosomes in Macrophages and Enhances Ang Ii-Induced Cardiac Inflammation

Lysosomal Cysteine Peptidase Cathepsin L Protects Against Cardiac Hypertrophy Through Blocking AKT/GSK3β Signaling

Myocardial Upregulation of Cathepsin D by Ischemic Heart Disease Promotes Autophagic Flux and Protects Against Cardiac Remodeling and Heart Failure.

Cathepsin S-mediated Fibroblast Trans-Differentiation Contributes to Left Ventricular Remodelling after Myocardial Infarction.

Cathepsin D Haploinsufficiency Exacerbates Post Myocardial Infarction Cardiac Remodeling and Malfunction by Impairing Autophagosome Removal

Endothelial S1pr1 Regulates Pressure Overload‐induced Cardiac Remodelling Through AKT‐eNOS Pathway

Pressure overload promotes cystatin C secretion of cardiomyocytes to regulate the MAPK signaling pathway and mediate cardiac hypertrophy

Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments

C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload

Abstract P234: CTMP Negatively Regulates Pathological Cardiac Hypertrophy via Akt-dependent Manner

Enhanced myocardial cathepsin B expression in patients with dilated cardiomyopathy.

Cardiomyocyte-Specific Deletion of Cathepsin K Protects Against Doxorubicin-Induced Cardiac Dysfunction

Cathepsin K Knockout Mitigates High-Fat Diet–Induced Cardiac Hypertrophy and Contractile Dysfunction

The Expression of Cathepsin S, K and Cystatin C During the Left Ventricular Remodeling in Rats with Pressure Overloaded Myocardial Hypertrophy

Ubiquitin specific protease 38 aggravates pathological cardiac remodeling by stabilizing phospho-TBK1

Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.

Exacerbating Pressure Overload–Induced Cardiac Hypertrophy